Skip to main content
Erschienen in: Cardiovascular Toxicology 4/2019

02.02.2019 | Atrioventricular Block

Measurement of J–Tpeakc along with QT-Interval Prolongation May Increase the Assay Sensitivity and Specificity for Predicting the Onset of Drug-Induced Torsade de Pointes: Experimental Evidences Based on Proarrhythmia Model Animals

verfasst von: Ai Goto, Mihoko Hagiwara-Nagasawa, Ryuichi Kambayashi, Koki Chiba, Hiroko Izumi-Nakaseko, Atsuhiko T. Naito, Yasunari Kanda, Atsushi Sugiyama

Erschienen in: Cardiovascular Toxicology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

dl-Sotalol which can block both K+ channel and ß-adrenoceptor has been shown to prolong the J–Tpeakc of electrocardiogram in beagle dogs but tended to shorten it in microminipigs, although the drug prolonged the QT interval in both animals under physiologically maintained experimental condition. In order to estimate how the changes in the J–Tpeakc in the normal hearts would be reflected in the pathologic hearts, we compared proarrhythmic effects of dl-sotalol by using proarrhythmia models of beagle dogs and microminipigs, of which atrioventricular node had been ablated > 2 months and 8–9 weeks before, respectively (n = 4 for each species). dl-Sotalol in an oral dose of 10 mg/kg induced torsade de pointes in three out of four beagle dogs, which degenerated into ventricular fibrillation. In microminipigs, the same dose did not trigger torsade de pointes at all, whereas intermittent ventricular pauses were observed in each animal after the drug treatment. These results indicate that assessment of the J–Tpeakc along with the QT-interval prolongation in healthy subjects may provide reliable information of risk prediction for patients susceptible to the drug-induced torsade de pointes.
Literatur
1.
Zurück zum Zitat Johannesen, L., Vicente, J., Mason, J. W., Erato, C., Sanabria, C., Waite-Labott, K., et al. (2016). Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial. Clinical Pharmacology & Therapeutics, 99, 214–223.CrossRef Johannesen, L., Vicente, J., Mason, J. W., Erato, C., Sanabria, C., Waite-Labott, K., et al. (2016). Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial. Clinical Pharmacology & Therapeutics, 99, 214–223.CrossRef
2.
Zurück zum Zitat Chiba, K., Wada, T., Nakamura, Y., Cao, X., Hagiwara-Nagasawa, M., Izumi-Nakaseko, H., et al. (2017). Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs. Journal of Pharmacological Sciences, 134, 239–246.CrossRefPubMed Chiba, K., Wada, T., Nakamura, Y., Cao, X., Hagiwara-Nagasawa, M., Izumi-Nakaseko, H., et al. (2017). Analysis of proarrhythmic potential of an atypical antipsychotic drug paliperidone in the halothane-anesthetized dogs. Journal of Pharmacological Sciences, 134, 239–246.CrossRefPubMed
3.
Zurück zum Zitat Cao, X., Nakamura, Y., Wada, T., Izumi-Nakaseko, H., Ando, K., & Sugiyama, A. (2016). Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs. The Journal of Toxicological Sciences, 41, 439–447.CrossRefPubMed Cao, X., Nakamura, Y., Wada, T., Izumi-Nakaseko, H., Ando, K., & Sugiyama, A. (2016). Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs. The Journal of Toxicological Sciences, 41, 439–447.CrossRefPubMed
4.
Zurück zum Zitat Matsukura, S., Nakamura, Y., Hoshiai, K., Hayashi, T., Koga, T., Goto, A., et al. (2018). Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study. Journal of Pharmacological Sciences, 136, 234–241.CrossRefPubMed Matsukura, S., Nakamura, Y., Hoshiai, K., Hayashi, T., Koga, T., Goto, A., et al. (2018). Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study. Journal of Pharmacological Sciences, 136, 234–241.CrossRefPubMed
5.
Zurück zum Zitat Vicente, J., Zusterzeel, R., Johannesen, L., Mason, J., Sager, P., Patel, V., et al. (2018). Mechanistic model-informed proarrhythmic risk assessment of drugs: Review of the “CiPA” initiative and design of a prospective clinical validation study. Clinical Pharmacology & Therapeutics, 103, 54–66.CrossRef Vicente, J., Zusterzeel, R., Johannesen, L., Mason, J., Sager, P., Patel, V., et al. (2018). Mechanistic model-informed proarrhythmic risk assessment of drugs: Review of the “CiPA” initiative and design of a prospective clinical validation study. Clinical Pharmacology & Therapeutics, 103, 54–66.CrossRef
6.
Zurück zum Zitat Motokawa, Y., Nakamura, Y., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Lubna, N. J., et al. (2018). In vivo analysis of the anti-atrial fibrillatory, proarrhythmic and cardiodepressive profiles of dronedarone as a guide for safety pharmacological evaluation of antiarrhythmic drugs. Cardiovascular Toxicology, 18, 242–251.CrossRefPubMed Motokawa, Y., Nakamura, Y., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Lubna, N. J., et al. (2018). In vivo analysis of the anti-atrial fibrillatory, proarrhythmic and cardiodepressive profiles of dronedarone as a guide for safety pharmacological evaluation of antiarrhythmic drugs. Cardiovascular Toxicology, 18, 242–251.CrossRefPubMed
7.
Zurück zum Zitat Matsukura, S., Nakamura, Y., Cao, X., Wada, T., Izumi-Nakaseko, H., Ando, K., et al. (2017). Anti-atrial fibrillatory versus proarrhythmic potentials of amiodarone: A new protocol for safety evaluation in vivo. Cardiovascular Toxicology, 17, 157–162.CrossRefPubMed Matsukura, S., Nakamura, Y., Cao, X., Wada, T., Izumi-Nakaseko, H., Ando, K., et al. (2017). Anti-atrial fibrillatory versus proarrhythmic potentials of amiodarone: A new protocol for safety evaluation in vivo. Cardiovascular Toxicology, 17, 157–162.CrossRefPubMed
8.
Zurück zum Zitat Harvey, R. D., & Grant, A. O. (2018). Agents used in cardiac arrhythmias. In B. G. Katzung (Ed.), Basic & clinical pharmacology (14th ed., pp. 212–227). New York: McGraw-Hill Education. Harvey, R. D., & Grant, A. O. (2018). Agents used in cardiac arrhythmias. In B. G. Katzung (Ed.), Basic & clinical pharmacology (14th ed., pp. 212–227). New York: McGraw-Hill Education.
9.
Zurück zum Zitat Yokoyama, H., Nakamura, Y., Saito, H., Nagayama, Y., Hoshiai, K., Wada, T., et al. (2017). Pharmacological characterization of microminipig as a model to assess the drug-induced cardiovascular responses for non-clinical toxicity and/or safety pharmacology studies. The Journal of Toxicological Sciences, 42, 93–101.CrossRefPubMed Yokoyama, H., Nakamura, Y., Saito, H., Nagayama, Y., Hoshiai, K., Wada, T., et al. (2017). Pharmacological characterization of microminipig as a model to assess the drug-induced cardiovascular responses for non-clinical toxicity and/or safety pharmacology studies. The Journal of Toxicological Sciences, 42, 93–101.CrossRefPubMed
10.
Zurück zum Zitat Ishizaka, T., Takahara, A., Iwasaki, H., Mitsumori, Y., Kise, H., Nakamura, Y., et al. (2008). Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs. Circulation Journal, 72, 1003–1011.CrossRefPubMed Ishizaka, T., Takahara, A., Iwasaki, H., Mitsumori, Y., Kise, H., Nakamura, Y., et al. (2008). Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs. Circulation Journal, 72, 1003–1011.CrossRefPubMed
11.
Zurück zum Zitat Lynch, J. J. III, Wilson, A. W., Hernandez, L. E., Nelson, R. A., Marsh, K. C., Cox, B. F., et al. (2008). Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys. British Journal of Pharmacology, 154, 1439–1445.CrossRefPubMedPubMedCentral Lynch, J. J. III, Wilson, A. W., Hernandez, L. E., Nelson, R. A., Marsh, K. C., Cox, B. F., et al. (2008). Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys. British Journal of Pharmacology, 154, 1439–1445.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Katagi, J., Nakamura, Y., Cao, X., Ohara, H., Honda, A., Izumi-Nakaseko, H., et al. (2016). Why can dl-sotalol prolong the QT interval in vivo despite its weak inhibitory effect on hERG K+ channels in vitro? Electrophysiological and pharmacokinetic analysis with the halothane-anesthetized guinea pig model. Cardiovascular Toxicology, 16, 138–146.CrossRefPubMed Katagi, J., Nakamura, Y., Cao, X., Ohara, H., Honda, A., Izumi-Nakaseko, H., et al. (2016). Why can dl-sotalol prolong the QT interval in vivo despite its weak inhibitory effect on hERG K+ channels in vitro? Electrophysiological and pharmacokinetic analysis with the halothane-anesthetized guinea pig model. Cardiovascular Toxicology, 16, 138–146.CrossRefPubMed
13.
Zurück zum Zitat Sugiyama, A. (2008). Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. British Journal of Pharmacology, 154, 1528–1537.CrossRefPubMedPubMedCentral Sugiyama, A. (2008). Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. British Journal of Pharmacology, 154, 1528–1537.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Thomsen, M. B., Verduyn, S. C., Stengl, M., Beekman, J. D., de Pater, G., van Opstal, J., et al. (2004). Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation, 110, 2453–2459.CrossRefPubMed Thomsen, M. B., Verduyn, S. C., Stengl, M., Beekman, J. D., de Pater, G., van Opstal, J., et al. (2004). Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation, 110, 2453–2459.CrossRefPubMed
15.
Zurück zum Zitat Verduyn, S. C., Vos, M. A., van der Zande, J., Kulcsàr, A., & Wellens, H. J. (1997). Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. Journal of the American College of Cardiology, 30, 1575–1584.CrossRefPubMed Verduyn, S. C., Vos, M. A., van der Zande, J., Kulcsàr, A., & Wellens, H. J. (1997). Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control. Journal of the American College of Cardiology, 30, 1575–1584.CrossRefPubMed
16.
Zurück zum Zitat Sugiyama, A., Nakamura, Y., Akie, Y., Saito, H., Izumi, Y., Yamazaki, H., et al. (2011). Microminipig, a non-rodent experimental animal optimized for life science research: In vivo proarrhythmia models of drug-induced long QT syndrome: Development of chronic atrioventricular block model of microminipig. Journal of the American College of Cardiology, 115, 122–126. Sugiyama, A., Nakamura, Y., Akie, Y., Saito, H., Izumi, Y., Yamazaki, H., et al. (2011). Microminipig, a non-rodent experimental animal optimized for life science research: In vivo proarrhythmia models of drug-induced long QT syndrome: Development of chronic atrioventricular block model of microminipig. Journal of the American College of Cardiology, 115, 122–126.
17.
Zurück zum Zitat Sugiyama, A., Ishida, Y., Satoh, Y., Aoki, S., Hori, M., Akie, Y., et al. (2002). Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. The Japanese Journal of Pharmacology, 88, 341–350.CrossRef Sugiyama, A., Ishida, Y., Satoh, Y., Aoki, S., Hori, M., Akie, Y., et al. (2002). Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. The Japanese Journal of Pharmacology, 88, 341–350.CrossRef
18.
Zurück zum Zitat Takahara, A., Sugiyama, A., Ishida, Y., Satoh, Y., Wang, K., Nakamura, Y., et al. (2006). Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias. British Journal of Pharmacology, 147, 634–641.CrossRefPubMed Takahara, A., Sugiyama, A., Ishida, Y., Satoh, Y., Wang, K., Nakamura, Y., et al. (2006). Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias. British Journal of Pharmacology, 147, 634–641.CrossRefPubMed
19.
Zurück zum Zitat Fridericia, L. S. (1920). Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken (in German). Acta Medica Scandinavica, 53, 469–486.CrossRef Fridericia, L. S. (1920). Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken (in German). Acta Medica Scandinavica, 53, 469–486.CrossRef
20.
Zurück zum Zitat Satoh, T., & Zipes, D. P. (1996). Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation, 94, 217–227.CrossRefPubMed Satoh, T., & Zipes, D. P. (1996). Rapid rates during bradycardia prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation, 94, 217–227.CrossRefPubMed
21.
Zurück zum Zitat Goto, A., Izumi-Nakaseko, H., Hagiwara-Nagasawa, M., Chiba, K., Ando, K., Naito, A. T., et al. (2018). Analysis of torsadogenic and pharmacokinetic profile of E-4031 in dogs bridging the gap of information between in vitro proarrhythmia assay and clinical observation in human subjects. Journal of Pharmacological Sciences, 137, 237–240.CrossRefPubMed Goto, A., Izumi-Nakaseko, H., Hagiwara-Nagasawa, M., Chiba, K., Ando, K., Naito, A. T., et al. (2018). Analysis of torsadogenic and pharmacokinetic profile of E-4031 in dogs bridging the gap of information between in vitro proarrhythmia assay and clinical observation in human subjects. Journal of Pharmacological Sciences, 137, 237–240.CrossRefPubMed
22.
Zurück zum Zitat Lubna, N. J., Nakamura, Y., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Kitta, K., et al. (2018). Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir. The Journal of Toxicological Sciences, 43, 507–512.CrossRefPubMed Lubna, N. J., Nakamura, Y., Hagiwara-Nagasawa, M., Goto, A., Chiba, K., Kitta, K., et al. (2018). Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir. The Journal of Toxicological Sciences, 43, 507–512.CrossRefPubMed
23.
Zurück zum Zitat Matsukura, S., Nakamura, Y., Cao, X., Wada, T., Izumi-Nakaseko, H., Ando, K., et al. (2017). Characterization of microminipigs as an in vivo experimental model for cardiac safety pharmacology. Journal of Pharmacological Sciences, 133, 103–109.CrossRefPubMed Matsukura, S., Nakamura, Y., Cao, X., Wada, T., Izumi-Nakaseko, H., Ando, K., et al. (2017). Characterization of microminipigs as an in vivo experimental model for cardiac safety pharmacology. Journal of Pharmacological Sciences, 133, 103–109.CrossRefPubMed
24.
Zurück zum Zitat Sugiyama, A., Satoh, Y., Ishida, Y., Yoneyama, M., Yoshida, H., & Hashimoto, K. (2002). Pharmacological and electrophysiological characterization of junctional rhythm during radiofrequency catheter ablation of the atrioventricular node: possible involvement of neurotransmitters from autonomic nervous system. Circulation Journal, 66, 696–701.CrossRefPubMed Sugiyama, A., Satoh, Y., Ishida, Y., Yoneyama, M., Yoshida, H., & Hashimoto, K. (2002). Pharmacological and electrophysiological characterization of junctional rhythm during radiofrequency catheter ablation of the atrioventricular node: possible involvement of neurotransmitters from autonomic nervous system. Circulation Journal, 66, 696–701.CrossRefPubMed
25.
Zurück zum Zitat Motomura, S., Iijima, T., Taira, N., & Hashimoto, K. (1975). Effects of neurotransmitters injected into the posterior and the anterior septal artery on the automaticity of the atrioventricular junctional area of the dog heart. Circulation Research, 37, 146–155.CrossRefPubMed Motomura, S., Iijima, T., Taira, N., & Hashimoto, K. (1975). Effects of neurotransmitters injected into the posterior and the anterior septal artery on the automaticity of the atrioventricular junctional area of the dog heart. Circulation Research, 37, 146–155.CrossRefPubMed
26.
Zurück zum Zitat Wada, T., Ohara, H., Nakamura, Y., Cao, X., Izumi-Nakaseko, H., Ando, K., et al. (2017). Efficacy of precordial percussion pacing assessed in a cardiac standstill microminipig model. Circulation Journal, 81, 1137–1143.CrossRefPubMed Wada, T., Ohara, H., Nakamura, Y., Cao, X., Izumi-Nakaseko, H., Ando, K., et al. (2017). Efficacy of precordial percussion pacing assessed in a cardiac standstill microminipig model. Circulation Journal, 81, 1137–1143.CrossRefPubMed
Metadaten
Titel
Measurement of J–Tpeakc along with QT-Interval Prolongation May Increase the Assay Sensitivity and Specificity for Predicting the Onset of Drug-Induced Torsade de Pointes: Experimental Evidences Based on Proarrhythmia Model Animals
verfasst von
Ai Goto
Mihoko Hagiwara-Nagasawa
Ryuichi Kambayashi
Koki Chiba
Hiroko Izumi-Nakaseko
Atsuhiko T. Naito
Yasunari Kanda
Atsushi Sugiyama
Publikationsdatum
02.02.2019
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 4/2019
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-019-09506-z

Weitere Artikel der Ausgabe 4/2019

Cardiovascular Toxicology 4/2019 Zur Ausgabe